Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120732514 | 12073251 | 4 | F | 200705 | 20160708 | 20160212 | 20160715 | EXP | US-PFIZER INC-2016075459 | PFIZER | 66.00 | YR | F | Y | 0.00000 | 20160715 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120732514 | 12073251 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 300 MG, 2X/DAY | 21446 | 300 | MG | CAPSULE, HARD | BID | ||||||
| 120732514 | 12073251 | 2 | SS | LYRICA | PREGABALIN | 1 | 21446 | CAPSULE, HARD | |||||||||||
| 120732514 | 12073251 | 3 | SS | NEURONTIN | GABAPENTIN | 1 | UNK | N | 20235 | ||||||||||
| 120732514 | 12073251 | 4 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 20 MG, 4X/DAY | 0 | 20 | MG | TABLET | QID | ||||||
| 120732514 | 12073251 | 5 | C | LIDODERM | LIDOCAINE | 1 | Transdermal | 5% 1 PATCH(S) APPLY ON THE SKIN EVERY 12 HOURS AROUND THE CLOCK | 0 | 5 | PCT | TRANSDERMAL PATCH | BID | ||||||
| 120732514 | 12073251 | 6 | C | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, 1X/DAY | 0 | 75 | MG | QD | |||||||
| 120732514 | 12073251 | 7 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 1 DF, 1X/DAY | 0 | 1 | DF | TABLET | QD | ||||||
| 120732514 | 12073251 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 100 UG, 1X/DAY | 0 | 100 | UG | TABLET | QD | ||||||
| 120732514 | 12073251 | 9 | C | ELIQUIS | APIXABAN | 1 | Oral | 2.5 MG, 2X/DAY | 0 | 2.5 | MG | TABLET | BID | ||||||
| 120732514 | 12073251 | 10 | C | OXYCODONE | OXYCODONE | 1 | Oral | 5 MG, 3X/DAY | 0 | 5 | MG | TABLET | TID | ||||||
| 120732514 | 12073251 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, 2X/DAY | 0 | 20 | MG | PROLONGED-RELEASE CAPSULE | BID | ||||||
| 120732514 | 12073251 | 12 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0.6/HALF TABLET(S) AS DIRECTED | 0 | TABLET | |||||||||
| 120732514 | 12073251 | 13 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 60 MG, UNK | 0 | 60 | MG | TABLET | |||||||
| 120732514 | 12073251 | 14 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 40 MG, UNK | 0 | 40 | MG | TABLET | |||||||
| 120732514 | 12073251 | 15 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | TABLET | |||||||
| 120732514 | 12073251 | 16 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | TABLET | |||||||
| 120732514 | 12073251 | 17 | C | LACTULOSE. | LACTULOSE | 1 | Oral | 1 SCOOP BY MOUTH DAILY | 0 | ||||||||||
| 120732514 | 12073251 | 18 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 1 DF, DAILY (HYDROCODONE 7.5 MG ACETAMINOPHEN 325 MG) | 0 | 1 | DF | TABLET | |||||||
| 120732514 | 12073251 | 19 | C | IBUPROFEN. | IBUPROFEN | 1 | Oral | 800 MG, 2X/DAY | 0 | 800 | MG | TABLET | BID | ||||||
| 120732514 | 12073251 | 20 | C | POTASSIUM 99 | 2 | Oral | 99 MG, DAILY | 0 | 99 | MG | TABLET | ||||||||
| 120732514 | 12073251 | 21 | C | CALCIUM | CALCIUM | 1 | Oral | 600 MG, 2X/DAY | 0 | 600 | MG | TABLET | BID | ||||||
| 120732514 | 12073251 | 22 | C | FISH OIL | FISH OIL | 1 | Oral | 1 DF, DAILY | 0 | 1 | DF | CAPSULE | |||||||
| 120732514 | 12073251 | 23 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, DAILY | 0 | 75 | MG | PROLONGED-RELEASE CAPSULE | |||||||
| 120732514 | 12073251 | 24 | C | PRIMIDONE. | PRIMIDONE | 1 | Oral | 100 MG, 2X/DAY | 0 | 100 | MG | TABLET | BID | ||||||
| 120732514 | 12073251 | 25 | C | LOVASTATIN. | LOVASTATIN | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | TABLET | |||||||
| 120732514 | 12073251 | 26 | C | FLUOCINOLONE | FLUOCINOLONE | 1 | Topical | 1 APPLICATION(S) APPLY ON THE SKIN AS DIRECTED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120732514 | 12073251 | 1 | Post herpetic neuralgia |
| 120732514 | 12073251 | 2 | Herpes zoster |
| 120732514 | 12073251 | 3 | Post herpetic neuralgia |
| 120732514 | 12073251 | 6 | Depression |
| 120732514 | 12073251 | 7 | Anxiety |
| 120732514 | 12073251 | 8 | Hypothyroidism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120732514 | 12073251 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120732514 | 12073251 | Blood sodium decreased | |
| 120732514 | 12073251 | Drug dependence | |
| 120732514 | 12073251 | Drug ineffective | |
| 120732514 | 12073251 | Emotional disorder | |
| 120732514 | 12073251 | Feeling abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120732514 | 12073251 | 1 | 200705 | 0 | ||
| 120732514 | 12073251 | 4 | 200710 | 0 | ||
| 120732514 | 12073251 | 5 | 200710 | 0 | ||
| 120732514 | 12073251 | 6 | 20160203 | 0 | ||
| 120732514 | 12073251 | 7 | 20120702 | 0 | ||
| 120732514 | 12073251 | 8 | 20080408 | 0 |